Related Experiment Video
Updated: Jul 14, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Low-dose hormone therapy in the perimenopause
P De Franciscis1, L Cobellis, F Fornaro
1Outpatient menopausal clinic, Department of Gynecology, Obstetrics and Reproductive Sciences, Second University of Naples, Largo Madonna delle Grazie, 80138 Naples, Italy. pasquale.defranciscis@unina2.it
Low-dose hormone therapy (LD-HT) effectively reduced hot flushes and improved bleeding patterns in perimenopausal women. This treatment offers a potential solution for managing common menopausal symptoms.
Area of Science:
- Reproductive Endocrinology
- Gynecology
- Menopause Management
Background:
- Perimenopause is characterized by irregular menstrual cycles and vasomotor symptoms like hot flushes.
- Hormone therapy is a common treatment, but optimal dosing for symptom control requires further investigation.
- Low-dose hormone therapy (LD-HT) presents a potential alternative for managing perimenopausal symptoms.
Purpose of the Study:
- To assess the efficacy of low-dose hormone therapy (LD-HT) in managing bleeding patterns and vasomotor symptoms.
- To compare the effects of sequential estrogen-progestogen LD-HT with progestogen-only therapy in perimenopausal women.
- To evaluate the impact of LD-HT on the frequency and severity of hot flushes.
Main Methods:
- A prospective, open-label study involving 120 perimenopausal women.
- Randomization into two groups: Group A received LD-HT (micronized 17beta-estradiol 1 mg plus dydrogesterone 10 mg sequential), and Group B received dydrogesterone 10 mg (days 15-28).
- Assessment of hot flush frequency/severity and bleeding patterns throughout the study period.
Main Results:
- Group A (LD-HT) demonstrated a significant reduction in the number of hot flushes compared to Group B.
- The incidence of cyclic bleeding was higher in Group A (86%) than in Group B (76%).
- Group A experienced a significantly shorter mean duration of bleeding compared to Group B.
Conclusions:
- Low-dose hormone therapy (LD-HT) is effective in controlling both irregular bleeding and hot flushes in perimenopausal women.
- Sequential estrogen-progestogen LD-HT offers a viable option for managing common menopausal symptoms.
- Further research may explore long-term effects and optimal LD-HT regimens.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Hormonal Regulation
Hormonal Regulation
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
